Aquestive Therapeutics (AQST) Cash & Equivalents (2017 - 2026)
Aquestive Therapeutics' Cash & Equivalents was $90.35 million in Q3 2026, down 30.0% from $129.06 million a year earlier and down 8.3% from the prior quarter.
Powered by 
Analysis
Aquestive Therapeutics (AQST) Cash & Equivalents (2017 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at Aquestive Therapeutics came in at $121.17 million, up 69.4% from FY2024.
- Cash & Equivalents shows a five-year compound annual growth rate of 30.7% (FY2020 to FY2025).
- In earlier years, Cash & Equivalents was $71.55 million in FY2024 (+199.7%), $23.87 million in FY2023 (-12.5%), $27.27 million in FY2022 (-2.7%) and $28.02 million in FY2021 (-11.9%).
- The Q3 2026 figure marks the lowest quarterly Cash & Equivalents since Q2 2025.
- Compared with a year earlier, Cash & Equivalents was higher in five of the last eight quarters, with growth averaging 46.0%.
- The best year-over-year quarter for Cash & Equivalents over five years was Q2 2024 (growth of 300.6%); the worst was Q2 2022 (a decline of 48.3%).
- Per Business Quant data, AQST's Cash & Equivalents in the three quarters before Q3 2026 was $98.49 million (Q2 2026), $110.73 million (Q1 2026) and $121.17 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Aquestive Therapeutics | 442.42 Mn | 21.68 Mn | 3.95 Mn | 90.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 90.35 Mn |
| Jun 30, 2026 | 98.49 Mn |
| Mar 31, 2026 | 110.73 Mn |
| Dec 31, 2025 | 121.17 Mn |
| Sep 30, 2025 | 129.06 Mn |
| Jun 30, 2025 | 60.54 Mn |
| Mar 31, 2025 | 68.66 Mn |
| Dec 31, 2024 | 71.55 Mn |
| Sep 30, 2024 | 77.89 Mn |
| Jun 30, 2024 | 89.87 Mn |
| Mar 31, 2024 | 95.20 Mn |
| Dec 31, 2023 | 23.87 Mn |
| Sep 30, 2023 | 24.92 Mn |
| Jun 30, 2023 | 22.44 Mn |
| Mar 31, 2023 | 26.88 Mn |
| Dec 31, 2022 | 27.27 Mn |
| Sep 30, 2022 | 18.65 Mn |
| Jun 30, 2022 | 17.70 Mn |
| Mar 31, 2022 | 14.74 Mn |
| Dec 31, 2021 | 28.02 Mn |
API Access
Aquestive Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=AQST&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "AQST", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=AQST&period=max&api_key=YOUR_API_KEY");
const data = await res.json();